As of March 2019, Amsterdam will be the proud home of the European Medicines Agency (EMA). It's been confirmed that the EMA will relocate its headquarters from London to Amsterdam due to Brexit. With a large number of pharma, medical technology companies, research institutions and more, the greater Amsterdam area has become one of the most attractive and fastest growing pharma and life science centres in the world.
"We see a large number of pharmaceuticals and Clinical
Research Organisations preparing for the regulatory changes
they'll have to deal with in the short term" - says
Jan Willem van Drimmelen, Head of Corporate Client Services at
Intertrust. "Over the past months we've seen a significant
increase in new clients, getting in contact with our experts in the
Netherlands".
The EMA is expected to provide job opportunities for 1,500 people,
including lawyers, patent specialists and consultants who are
expected to move to Amsterdam to be close to the organisation. In
addition, pharmaceutical companies are likely to set up a
subsidiary in the Netherlands. For the Dutch pharmaceutical
industry, the arrival of the EMA will be a big boost noted by
companies and investors worldwide.
The benefits of the Netherlands
- Internationally leading the Life Sciences & Health Sector
- Ranked No. 3 in the world by Forbes' "Best Countries for Business"
- Perfect springboard into the European Union
- World-class health and research institutes
- Excellent logistics infrastructure and modern network of roads and highways
If you are considering relocating your business to the Netherlands, or to another EU-country, please don't hesitate to get in contact. We have a team of specialists who can help you navigate all relevant local regulations and enable the setup of a legal entity, financial administration, payroll and all corporate secretarial services. Furthermore, we can support you with your local staffing and office space requirements providing tailor made solutions.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.